NBCA Survey Shows Gaps in DVT/PE Prophylaxis Among Hospitalized Patients

Data Demonstrate Patient Awareness is Low, Despite Increased Risks

blood clot preventionData from NBCA’s online survey of 500 patients who had been hospitalized for >3 days, show that less than one-third of respondents report DVT prophylaxis with either an anticoagulant pill or anticoagulant injection, even though more than 40% of them report that they had a family member who previously had a blood clot in the leg or lung, and 15% say they had a personal history of a blood clot in the leg or lung.  DVT prophylaxis reported by respondents include:  63% ambulation, 39% compression stockings, 37% mechanical compression, 37% aspirin, 29% anticoagulant injection, and 28% anticoagulant pill. These survey findings are compelling, because they demonstrate the gaps that need to be filled to optimize use of evidence-based DVT/PE prophylaxis, as well as the need to better inform or educate our hospitalized patients about potential risk factors.

Risk Versus Awareness – Read More…
General Public Vs. At-Risk Oncology and Hospitalized Samples  – Read More…
Hospital Findings Quick Facts – Read More…
Survey Methodology – Read More…

1 | 2 | 3 | 4 | 5   Next>>>

The NBCA DVT/PE Awareness Survey was made possible by a grant from Ortho-McNeil™, a Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.

Current News

October e-Newsletter | Support World Thrombosis Day 2018

This year, NBCA is celebrating 15 years of service in the clotting disorders community, and our mission has long been to advance…

Expecting or recently had a baby? Don’t let a blood clot spoil your joy.

Today, the National Blood Clot Alliance, in collaboration with the Centers for Disease Control and Prevention, kicked off the next phase…